Walleye Capital’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$502K Buy
2023
Q4
$206K Sell
2023
Q3
$1.17M Buy
2023
Q1
Sell
2022
Q4
$9.48M Buy
2022
Q3
$935K Buy
2022
Q1
Sell
2021
Q4
$281K Buy
2021
Q3
$138 Sell
2021
Q2
$371 Sell
2021
Q1
$640 Buy